Nifty

:

25722.10

Sensex

:

83938.71

-155.75 (-0.60%)
-465.75 (-0.55%)

Login

Nifty
Sensex

:
:

25722.10
83938.71

-155.75 (-0.60%)
-465.75 (-0.55%)

Aarey Drugs & Pharmaceuticals Ltd.

Trading

Rating :

66/99

BSE: 524412 | NSE: AAREYDRUGS

Watchlist

NSE BSE

94.97

31-Oct-2025

Open
High
Low
Previous Close

91.7
94.97
91.24
93.11

Volume
Traded Value (lacs)
52 Week High
52 Week Low

61836
5802772.13
94.97
31.35

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

267.81
64.45
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

301.19
N/A
1.95

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.37
5.68
-7.06

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.59
6.62
-17.14

PAT CAGR (%)

10 Years
5 Years
3 Years

15.69
-4.17
-10.60

P:E (Median)

8 Years
5 Years
3 Years

15.36
22.87
29.25

P:BV (Average)

8 Years
5 Years
3 Years

0.92
0.96
1.05

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.05
11.77
14.04

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 102.21 126.91 -19.46% 108.10 210.35 -48.61% 133.79 76.48 74.93% 105.14 57.83 81.81%
Expenses 100.51 125.73 -20.06% 112.30 211.79 -46.98% 131.59 73.77 78.38% 101.42 55.98 81.17%
EBITDA 1.70 1.18 44.07% -4.20 -1.44 - 2.20 2.70 -18.52% 3.72 1.85 101.08%
EBIDTM 1.67% 0.93% -3.89% -0.68% 1.65% 3.53% 3.54% 3.19%
Other Income 1.55 1.57 -1.27% 7.54 5.14 46.69% 0.68 0.29 134.48% 0.02 0.84 -97.62%
Interest 1.04 0.96 8.33% 3.13 1.16 169.83% 0.90 1.06 -15.09% 1.51 1.27 18.90%
Depreciation 0.49 0.47 4.26% -1.42 0.40 - 0.58 0.47 23.40% 0.49 0.41 19.51%
PBT 1.73 1.33 30.08% 1.63 2.15 -24.19% 1.40 1.46 -4.11% 1.75 1.01 73.27%
Tax 0.36 0.09 300.00% 1.16 -0.01 - 0.68 0.44 54.55% 0.15 0.22 -31.82%
PAT 1.37 1.24 10.48% 0.47 2.15 -78.14% 0.72 1.02 -29.41% 1.60 0.78 105.13%
PATM 1.34% 0.98% 0.43% 1.02% 0.54% 1.34% 1.52% 1.36%
EPS 0.48 0.44 9.09% 0.17 0.76 -77.63% 0.25 0.36 -30.56% 0.56 0.28 100.00%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 449.24 395.62 418.96 492.76 348.42 300.09 354.71 348.63 395.97 246.03 213.44 Net Sales Growth -4.74% -5.57% -14.98% 41.43% 16.11% -15.40% 1.74% -11.96% 60.94% 15.27% Cost Of Goods Sold 436.30 375.37 397.53 466.12 334.50 290.18 340.97 337.37 382.99 241.99 209.67 Gross Profit 12.94 20.25 21.42 26.65 13.92 9.91 13.73 11.27 12.98 4.03 3.77 GP Margin 2.88% 5.12% 5.11% 5.41% 4.00% 3.30% 3.87% 3.23% 3.28% 1.64% 1.77% Total Expenditure 445.82 391.17 411.23 481.37 343.77 296.86 346.82 340.99 386.36 245.02 212.08 Power & Fuel Cost - 0.03 0.03 0.04 0.00 0.01 0.04 0.04 0.04 0.07 0.03 % Of Sales - 0.01% 0.01% 0.01% 0% 0.00% 0.01% 0.01% 0.01% 0.03% 0.01% Employee Cost - 0.54 0.63 0.67 0.20 0.29 0.37 0.35 0.34 0.26 0.26 % Of Sales - 0.14% 0.15% 0.14% 0.06% 0.10% 0.10% 0.10% 0.09% 0.11% 0.12% Manufacturing Exp. - 11.27 7.93 8.00 4.55 1.54 1.94 0.07 0.00 0.77 0.46 % Of Sales - 2.85% 1.89% 1.62% 1.31% 0.51% 0.55% 0.02% 0% 0.31% 0.22% General & Admin Exp. - 2.47 3.08 3.42 2.00 1.40 1.19 1.88 1.47 0.95 0.88 % Of Sales - 0.62% 0.74% 0.69% 0.57% 0.47% 0.34% 0.54% 0.37% 0.39% 0.41% Selling & Distn. Exp. - 1.23 1.31 2.15 1.86 3.37 2.28 1.12 1.43 0.91 0.72 % Of Sales - 0.31% 0.31% 0.44% 0.53% 1.12% 0.64% 0.32% 0.36% 0.37% 0.34% Miscellaneous Exp. - 0.26 0.71 0.97 0.66 0.06 0.03 0.17 0.10 0.07 0.72 % Of Sales - 0.07% 0.17% 0.20% 0.19% 0.02% 0.01% 0.05% 0.03% 0.03% 0.03% EBITDA 3.42 4.45 7.73 11.39 4.65 3.23 7.89 7.64 9.61 1.01 1.36 EBITDA Margin 0.76% 1.12% 1.85% 2.31% 1.33% 1.08% 2.22% 2.19% 2.43% 0.41% 0.64% Other Income 9.79 6.96 2.73 2.67 7.01 6.69 4.34 3.18 3.34 3.14 2.59 Interest 6.58 4.38 2.87 2.04 2.44 1.79 2.23 1.92 4.33 1.72 1.49 Depreciation 0.14 1.70 1.57 1.99 0.92 0.89 1.01 0.71 0.64 0.62 1.05 PBT 6.51 5.34 6.01 10.04 8.30 7.24 8.99 8.19 7.98 1.81 1.41 Tax 2.35 0.66 2.24 3.48 1.79 1.45 2.44 2.01 2.50 0.52 0.32 Tax Rate 36.10% 12.36% 37.27% 34.66% 21.57% 20.03% 27.14% 24.54% 31.33% 28.73% 22.70% PAT 4.16 4.68 3.77 6.55 6.51 5.79 6.54 6.18 5.47 1.29 1.09 PAT before Minority Interest 4.16 4.68 3.77 6.55 6.51 5.79 6.54 6.18 5.47 1.29 1.09 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.93% 1.18% 0.90% 1.33% 1.87% 1.93% 1.84% 1.77% 1.38% 0.52% 0.51% PAT Growth -19.85% 24.14% -42.44% 0.61% 12.44% -11.47% 5.83% 12.98% 324.03% 18.35% EPS 1.46 1.65 1.33 2.31 2.29 2.04 2.30 2.18 1.93 0.45 0.38

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 132.77 117.41 113.64 98.86 92.35 86.55 80.24 49.19 36.70 35.41 Share Capital 28.05 25.38 25.38 23.38 23.38 23.38 23.38 18.08 16.81 16.81 Total Reserves 102.25 89.71 85.94 73.16 66.65 60.85 54.55 30.07 19.88 18.59 Non-Current Liabilities 3.97 5.78 4.80 3.37 1.46 1.53 1.35 1.61 0.09 0.00 Secured Loans 3.22 4.36 3.34 0.00 0.02 0.04 0.06 0.07 0.09 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 1.81 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 166.55 168.14 126.74 130.80 100.28 57.63 88.19 91.70 88.21 79.54 Trade Payables 128.94 127.33 109.66 110.34 77.75 37.28 77.58 74.55 71.95 67.14 Other Current Liabilities 5.41 2.18 1.03 0.78 2.00 0.37 4.26 4.38 0.63 0.28 Short Term Borrowings 28.13 33.36 10.82 18.02 17.87 16.12 3.18 10.32 14.45 11.02 Short Term Provisions 4.06 5.28 5.23 1.66 2.66 3.86 3.18 2.45 1.19 1.09 Total Liabilities 303.29 291.33 245.18 233.03 194.09 145.71 169.78 142.50 125.00 114.95 Net Block 12.96 13.94 14.47 14.26 12.30 12.27 11.71 12.15 7.85 5.89 Gross Block 33.89 33.17 32.13 29.93 27.05 26.13 24.56 24.28 19.35 16.77 Accumulated Depreciation 20.93 19.23 17.66 15.67 14.75 13.86 12.85 12.14 11.50 10.88 Non Current Assets 20.71 20.72 26.35 14.66 12.74 12.72 12.50 12.61 8.29 6.33 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.34 0.00 0.00 0.00 Non Current Investment 1.38 0.40 0.40 0.40 0.44 0.44 0.44 0.44 0.44 0.44 Long Term Loans & Adv. 6.36 6.37 9.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.01 0.01 2.40 0.00 0.00 0.01 0.01 0.03 0.00 0.00 Current Assets 282.59 270.61 218.82 218.38 181.34 132.99 157.29 129.88 116.71 108.59 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 34.68 28.82 13.68 18.46 17.00 21.25 14.77 5.21 2.08 4.17 Sundry Debtors 184.48 189.78 136.28 162.01 96.13 105.74 95.30 81.86 72.48 66.71 Cash & Bank 1.59 0.71 0.19 0.65 0.50 0.37 3.39 1.04 1.62 0.17 Other Current Assets 61.84 0.75 0.66 2.81 67.71 5.63 43.83 41.78 40.53 37.53 Short Term Loans & Adv. 59.12 50.55 68.00 34.45 65.86 4.59 43.72 41.78 40.53 37.53 Net Current Assets 116.04 102.47 92.08 87.57 81.07 75.36 69.10 38.18 28.49 29.05 Total Assets 303.30 291.33 245.17 233.04 194.08 145.71 169.79 142.49 125.00 114.95

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -2.99 -1.28 0.50 5.48 2.86 0.69 -20.35 0.62 5.66 3.25 PBT 5.34 6.01 10.03 8.30 7.24 8.99 8.19 7.98 1.81 1.41 Adjustment 5.41 4.44 3.99 3.35 2.68 3.24 2.63 5.02 2.37 2.57 Changes in Working Capital -12.42 -9.45 -9.93 -4.51 -5.56 -9.29 -28.56 -10.27 1.48 -0.73 Cash after chg. in Working capital -1.67 1.00 4.09 7.14 4.36 2.94 -17.74 2.72 5.66 3.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.32 -2.28 -3.59 -1.66 -1.50 -2.25 -2.61 -2.10 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.70 0.44 -3.21 -2.88 -0.92 -1.23 -0.60 -4.96 -2.58 -2.43 Net Fixed Assets -0.72 -1.04 -2.20 -2.88 -0.92 -1.23 -0.62 -4.93 -2.58 -2.43 Net Investments -0.98 0.00 0.00 0.04 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.00 1.48 -1.01 -0.04 0.00 0.00 0.02 -0.03 0.00 0.00 Cash from Financing Activity 5.58 1.35 2.25 -2.45 -1.80 -2.48 23.31 3.75 -1.63 -1.50 Net Cash Inflow / Outflow 0.89 0.51 -0.46 0.15 0.13 -3.02 2.35 -0.58 1.45 -0.68 Opening Cash & Equivalents 0.71 0.19 0.65 0.50 0.37 3.39 1.04 1.62 0.00 0.85 Closing Cash & Equivalent 1.59 0.71 0.19 0.65 0.50 0.37 3.39 1.04 1.62 0.17

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 46.45 45.34 43.85 41.29 38.50 36.02 33.33 26.63 21.82 21.04 ROA 1.58% 1.41% 2.74% 3.05% 3.41% 4.15% 3.96% 4.09% 1.07% 0.98% ROE 3.82% 3.33% 6.31% 6.98% 6.65% 8.07% 9.80% 12.90% 3.58% 3.12% ROCE 6.09% 6.28% 9.87% 9.46% 8.48% 12.05% 14.14% 22.21% 7.23% 6.69% Fixed Asset Turnover 11.80 12.83 15.88 12.23 11.29 14.00 14.30 18.15 13.62 13.87 Receivable days 172.65 142.03 110.48 135.22 122.77 103.43 92.55 71.13 103.25 112.49 Inventory Days 29.29 18.51 11.91 18.57 23.26 18.53 10.44 3.36 4.63 7.95 Payable days 124.60 108.80 86.14 102.62 71.79 59.35 79.48 68.80 104.65 113.37 Cash Conversion Cycle 77.34 51.75 36.24 51.17 74.24 62.62 23.51 5.69 3.23 7.07 Total Debt/Equity 0.24 0.33 0.13 0.19 0.20 0.19 0.04 0.22 0.40 0.31 Interest Cover 2.22 3.10 5.93 4.40 5.06 5.03 5.27 2.84 2.06 1.95

Top Investors:

krishnamurthy c g

chetan kiritbhai mehta

archana pramod wani

vijaykumar babulal shah

Annual Reports:

News Update:

Aarey Drugs & Pharma - Quarterly Results
13th Aug 2025, 17:41 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback